用于减轻甲的料添加剂:在反动物研究中测试肠道减轻甲的料添加剂的建议
Alexander N Hristov1, André Bannink2, Marco Battelli3
1Department of Animal Science, The Pennsylvania State University, University Park, PA 16802.
Journal of dairy science
|December 26, 2024
概括
对于抗甲基料添加剂 (AMFA) 需要严格的测试标准,以减少反动物的肠道甲排放. 本综述概述了研究设计,数据分析和甲测量的指导方针,以确保可靠的疗效确认.
科学领域:
- 动物营养与环境科学.
- 农业技术和可持续性.
背景情况:
- 来自反动物的肠道甲排放对温室气体有很大贡献.
- 抗甲基素料添加剂 (AMFA) 是一个有希望的缓解策略.
- 目前对AMFA的测试标准缺乏科学严谨性和标准化.
研究的目的:
- 为在反动物中对AMFA进行科学测试提供指导方针.
- 建立标准来评估料添加剂的抗甲基和生产效应.
- 为了确保可靠的疗效确认,在提出缓解要求之前.
主要方法:
- 关于研究设计的建议,包括假设的制定和统计分析.
- 评估饮食效应,与其他策略的关联效应以及生产反应的指导方针.
- 评估适当的甲测量技术 (呼吸室,SF6,GreenFeed) 和生理/健康影响.
主要成果:
- 提出了评估AMFA有效性和安全性的综合框架.
- 强调需要长期研究和生产系统的代表性实验.
- 强调收集和分析生产,健康和产品质量数据的重要性.
结论:
- 标准化,科学健全的测试对于验证AMFA至关重要.
- 遵守拟议的指导方针将确保实际和适用的结果.
- 对AMFA的有效性声明只应在经过严格的动物研究后进行确认.
相关概念视频
01:31Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
In the complex environment of the gastric lumen, excessive acid secretion can lead to the formation or worsening of ulcers within the delicate mucosal layer. Antacids, such as sodium bicarbonate and calcium carbonate, provide relief by neutralizing this acid, transforming it into harmless salt and water. This neutralization process raises the gastric pH from a highly acidic level of 1 to a more basic 3-4, reducing the acidity within the stomach.
However, this neutralization reaction between...
However, this neutralization reaction between...
01:24Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
01:20Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
Adsorbents...
01:21Drugs for Treatment of Constipation-Predominant IBS
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
01:29Drugs for Treatment of Ulcerative Colitis in IBD
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...